Aptevo Therapeutics

About:

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

Website: http://www.aptevotherapeutics.com/

Description:

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIRâ„¢ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.

Total Funding Amount:

$60M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2016-01-01

Contact Email:

CustomerService(AT)apvo.com

Founders:

Marvin L. White

Number of Employees:

101-250

Last Funding Date:

2024-09-16

IPO Status:

Public

Industries:

© 2025 bioDAO.ai